Biostage (BSTG)
OTHER OTC:BSTG
US Market
Holding BSTG?
Track your performance easily

Biostage (BSTG) Income Statement

0 Followers

Biostage Income Statement

Last quarter (Q ), Biostage's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Biostage's net income was $2.88M. See Biostage’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 61.00K$ 87.00K$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
---$ 0.00$ 0.00-
Gross Profit
-$ 87.00K-$ 0.00$ 0.00$ 0.00
Operating Expense
$ -1.93M$ 6.33M$ 8.47M$ 4.88M$ 8.40M$ 7.44M
Operating Income
$ -984.00K$ -6.25M$ -8.47M$ -4.88M$ -8.40M$ -7.44M
Net Non Operating Interest Income Expense
------
Other Income Expense
$ 239.00K$ 7.00K$ 493.00K$ 13.00K$ 65.00K$ -89.00K
Pretax Income
$ -1.10M$ -6.25M$ -7.98M$ -4.87M$ -8.33M$ -7.53M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -1.19M$ -6.25M$ -7.98M$ -4.87M$ -8.33M$ -7.53M
Basic EPS
$ -0.58$ -0.54$ -0.79$ -0.55$ -1.21$ -1.69
Diluted EPS
$ -0.04$ -0.54$ -0.79$ -0.55$ -1.21$ -1.69
Basic Average Shares
$ 46.40M$ 11.35M$ 10.06M$ 8.79M$ 6.90M$ 4.46M
Diluted Average Shares
$ 35.05M$ 11.35M$ 10.06M$ 8.79M$ 6.90M$ 4.46M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -1.93M$ 6.33M$ 8.47M$ 4.88M$ 8.40M$ 7.44M
Net Income From Continuing And Discontinued Operation
$ -6.87M$ -6.25M$ -7.98M$ -4.87M$ -8.33M$ -7.53M
Normalized Income
$ -2.40M-$ -8.40M$ -4.88M$ -8.40M$ -7.45M
Interest Expense
------
EBIT
$ -1.15M$ -6.25M$ -8.47M$ -4.88M$ -8.40M$ -7.44M
EBITDA
$ -1.10M$ -6.07M$ -8.36M$ -4.69M$ -8.18M$ -7.18M
Currency in USD

Biostage Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis